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Summary
Objective: An association between osteoarthritis (OA) and functional polymorphisms in the aspartic acid (D) repeat of the asporin (ASPN )
gene was reported in Japanese and Han Chinese populations. The aim of this study was to assess the association of variants in the
ASPN gene with the presence of radiographic hand and/or knee OA in a US Caucasian population.
Methods: Ten single nucleotide polymorphisms (SNPs) within the ASPN gene were genotyped in 775 affected siblings with radiographically
conﬁrmed hand and/or knee OA, and the allelic, genotypic and haplotypic association results were examined.
Results: One variant (SNP RS7033979) showed nominal evidence of association with both hand OA (P¼ 0.042) and knee OA (P¼ 0.032).
Four additional SNPs showed nominal evidence of association with knee OA only. These associations were only observed with genotypic
tests; the corresponding allelic and haplotype tests did not corroborate the single-point association results.
Conclusion: These data suggest that polymorphisms within ASPN are not a major inﬂuence in susceptibility to hand or knee OA in US
Caucasians.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is characterized by both degenerative
and reactive changes in the articular cartilage and sub-
chondral bone, thought to be driven by a spectrum of
environmental and genetic factors operating via both bio-
mechanical and biochemical mechanisms1,2. The changes
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1174extracellular matrix (ECM) and collagen breakdown due
to a combination of increased catabolism and decreased
synthesis. Asporin (ASPN) is a member of the small leu-
cine-rich proteoglycan subfamily of proteins3, members of
which bind to transforming growth factor-b (TGF-b), an
important regulator of cartilage homeostasis, and to other
ECM molecules of cartilage, including collagens4. ASPN
is expressed at low levels in normal cartilage but is ex-
pressed abundantly in OA articular cartilage3,5. Variant
ASPN proteins arise due to a microsatellite in the ASPN
coding sequence that determines a variable number of
aspartic acid (D) repeats in the amino-terminal end of the
protein. A genetic association study conducted by Kizawa
and colleagues identiﬁed a variant of ASPN as a susceptibil-
ity factor for OA5. Allele D14 was signiﬁcantly more
1175Osteoarthritis and Cartilage Vol. 16, No. 10common in Japanese hip and knee OA patients compared
with controls5, suggesting that the D14 allele may lead to
an increased OA liability in the Japanese population. An as-
sociation of the D14 allele with knee OA susceptibility was
also observed in a Han Chinese population6,7. However,
subsequent replication studies in European Caucasians
gave inconsistent results8e10, suggesting that the associa-
tion of ASPN polymorphisms with OA susceptibility varies
in different ethnic populations. The D14 allele codes for
a variant form of ASPN that appears to be more active
than other forms at inhibiting TGF-b activity. A variant of
ASPN coded by the D13 allele appears to have reduced
binding to TGF-b and has been associated with a reduced
susceptibility to OA5. The purpose of the present study
was to assess the association of variants in the ASPN
gene with OA in a US Caucasian population.Patients and methodsPATIENTS AND CONTROLSThe design of the Genetics of Generalized OA (GOGO) study has been
published previously11. The overall aim of the GOGO study is to identify re-
gions in the human genome associated with increased susceptibility to gen-
eralized OA. For the current analysis, 786 siblings with multiple-joint OA from
533 nuclear families (330 families with one affected sibling and 203 families
with more than one affected sibling) were sampled. Only affected siblings
from the US sites (Case Western Reserve University, OH; Duke University
Medical Center, NC; Rush Medical College, IL; University of Maryland,
MD; and University of North Carolina (UNC), NC) were selected for inclusion
in this study. In addition, a set of 513 unrelated matched controls were re-
cruited from North Carolina. These were randomly selected from controls
in the GO (Genetics of OA) study directed by Dr Joanne Jordan at UNC.
These controls underwent the same stringent radiographic phenotyping as
cases and failed to meet the case deﬁnitions described below. After geno-
typic quality control, 11 subjects from the case group and two from the con-
trol group were excluded from further analysis because of low subject
genotyping efﬁciency (<70%). Therefore, the results presented here are
based on 775 affected siblings from 528 nuclear families and 511 unrelated
control subjects group-matched by age and sex. The phenotypes analyzed
were generalized OA of the hand joints and of at least one knee (740 and
572 affected siblings had hand OA and knee OA phenotypes, respectively).
All family-based cases and unrelated controls were Caucasian, 18 years
and provided written informed consent. The ascertainment and phenotypic
analysis of participating individuals and families were performed as previ-
ously described11. Demographic characteristics of individuals included in
this study are summarized in Table I.CASE DEFINITIONSRadiographic hand OA was characterized from posterior anterior ﬁlms
focused on the third metacarpo-phalangeal joint, using the Kellgrene
Lawrence (KL) grading scheme12. Radiographs were also assessed for
individual features, including joint space narrowing (JSN), osteophytes
and other joint-speciﬁc features using a photographic standard atlas13.
Individuals were classiﬁed as having hand OA if they met the following
criteria: (1) involvement of 3 joints (KL grade 2), including at least
one distal interphalangeal (DIP) joint of digits 2e5; (2) two of the three in-
volved joints within the same joint group [DIP, proximal interphalangeal
(PIP) or carpal metacarpal (CMC)]; and (3) evidence of OA observed in
both hands (bilateral hand involvement).Table I
Demographic characteristics of the case and control samples
Controls (n¼ 511) Cases (n¼ 775)
Female
(n¼ 341)
Male
(n¼ 170)
Female
(n¼ 630)
Male
(n¼ 145)
Mean age (SD),
years
67.5 (7.1) 69.6 (7.0) 70.8 (8.6) 70.9 (7.6)
Mean body mass
index (SD), kg/m2
26.5 (4.5) 28.1 (4.1) 29.6 (6.5) 29.1 (5.5)Radiographic knee OA of the medial or lateral tibio-femoral compartments
was deﬁned as KL grade 2 or joint replacement in at least one knee, the
latter requiring veriﬁcation that the joint replacement occurred for OA.GENOTYPINGA marker selection algorithm was used to select SNPs that were likely to
contribute independent genetic information from the HapMap data14. The av-
erage spacing between markers was one SNP per 3.5 kb for production gen-
otyping. The critical aspartic acid (D) repeat polymorphism, nonsynonomous
coding SNPs and SNPs in intron lariat regions were added to create the ﬁnal
marker set for the ASPN gene.
The D repeat microsatellite was genotyped by polymerase chain reaction
(PCR) ampliﬁcation using 20 ng of genomic DNA with the primers 50-6-FAM-
ATTCCTGGCTTTGTGCTCTG-30 and 50-CTCGTGAATAGCACTGACATC
C-30. PCR was performed using AmpliTaq Gold (Applied Biosystems, Foster
City, CA) as follows: seven cycles at 98C for 10 s, 60C for 1 min and 70C
for 1 min, followed by 31 cycles at 96C for 10 s and 68C for 1 min. Ampli-
ﬁed PCR products were diluted 1:30 with water, from which 1.0 ml of each
sample was transferred into a 19.0 ml master mix containing 18.5 ml HiDi
Formamide (Applied Biosystems), and 0.5 ml GeneScan 500 ROX Size Stan-
dard (Applied Biosystems). Samples were heated to 95C for 5 min and im-
mediately placed on ice before being analyzed on the 3730xl DNA Analyzer
(Applied Biosystems). Peak proﬁles were analyzed using GeneMapper v3.0
software (Applied Biosystems). The number of aspartic acid repeats was de-
termined by PCR fragment size.
Genotyping for the other nine SNPs was performed by a modiﬁcation of
the single base chain extension (SBCE) assay15. Following genotyping,
the data were scored using a modiﬁcation of Spotﬁre Decision Site (version
8.1).
Genotypes for all assays that passed our internal quality control assess-
ment were then exported to an analysis database for statistical analysis.STATISTICAL ANALYSISEach SNP was tested for association with hand and knee OA. In addition,
haplotypic tests were also performed for each phenotype. In order to perform
caseecontrol analysis using related cases and/or controls, it was necessary
to account for correlations between related individuals due to identity-by-
descent. The CCREL method16 accounts for these correlations, employing
a composite likelihood approach with weights based on kinship coefﬁcients.
An expectation maximization-style algorithm is used to resolve missing ge-
notypes and phase, and P values for the caseecontrol tests are based on
asymptotic approximation to a chi-square distribution.
The effective numbers of cases and controls represent the equivalent
number of unrelated individuals yielding the same amount of information. Be-
cause correlations between related individuals result in reduced information,
a group of related individuals has an effective sample size less than the total
number of individuals in the group. The CCREL method does not allow for
cases to be related to controls. Therefore, a set of independent controls (un-
related to cases) were used to test for association in this experiment. While
the tests are based on asymptotic approximation, the results are fairly robust
to small sample sizes and low allele/genotype/haplotype frequencies.
The D repeat polymorphism has 10 alleles. Only three of the 10 alleles oc-
cur at more than 10% frequency in these data. We tested for association with
this marker by testing each of the common alleles, in turn, against the rest,
pooled.
For each marker that showed evidence of association with OA, genotypic
odds ratios [ORs, with 95% CIs (conﬁdence intervals)] were calculated with
respect to carriers of the minor allele compared with the major allele.Results
Ten markers, including the critical aspartic acid (D) repeat
polymorphism, were analyzed in the ASPN gene. The sin-
gle-point allelic and genotypic association results are pre-
sented in Table II. The D repeat polymorphism that was
originally found to be associated with OA in a Japanese
cohort was not associated with OA in this population. How-
ever, one variant (SNP RS7033979) did show nominal
evidence of association with both hand OA (P¼ 0.042;
OR¼ 0.59, 95% CI 0.37e0.95) and knee OA (P¼ 0.032;
OR¼ 0.62, 95% CI 0.39e0.98). This SNP was not typed
in the original Japanese study. Four additional SNPs
showed nominal evidence of association with knee OA
only; SNP RS8067 (P¼ 0.021; OR¼ 1.7, 95% CI
1.16e2.49), SNP RS1924243 (P¼ 0.013; OR¼ 0.53, 95%
Table II
Association of the D repeat of ASPN in patients with hand or knee OA (significant associations shown in bold)
RefSeq
number
Hand OA Knee OA
Allelic
P value
Genotypic
P value
Haplotypic
Win2
P value
Haplotypic
Win3
P value
Allelic
P value
Genotypic
P value
Haplotypic
Win2
P value
Haplotypic
Win3
P value
RS8067 0.20825 0.08242 0.38729 0.55833 0.13659 0.02062 0.2721 0.42854
RS3174352 0.68177 0.18551 0.91549 0.42644 0.53847 0.10218 0.79982 0.58827
RS17591776 0.80182 0.97578 0.27394 0.36844 0.6706 0.91976 0.45573 0.50171
RS4744132 0.10972 0.10508 0.21633 0.30305 0.23487 0.23198 0.35105 0.37404
RS7033979 0.40091 0.04283 0.50359 0.67503 0.3573 0.03193 0.36919 0.57446
RS1924243 0.26518 0.10127 0.47972 0.4203 0.15664 0.0133 0.37429 0.33736
RS10992350 0.60734 0.61809 0.87366 0.34726 0.34178 0.56173 0.63027 0.26256
Aspartic acid (D) repeat *
D13 vs others 0.98351 0.11158 0.23542 0.26907 0.90338 0.05921 0.14552 0.17729
D14 vs others 0.42511 0.51518 0.35717 0.38451 0.29767 0.43079 0.25925 0.29851
D15 vs others 0.57046 0.53326 0.60626 0.68233 0.3944 0.48494 0.43791 0.51028
RS3739606 0.18939 0.07853 0.2212 0.2212 0.10949 0.01578 0.13556 0.13556
RS7860786 0.25846 0.07853 0.2212 0.40164 0.13016 0.01232 0.13556 0.27841
*The aspartic acid (D) repeat polymorphism has 10e19 aspartic acid (D) residues (10 alleles) in our data [cases and controls combined;
number of repeats (freq): D10 (0.0007), D11 (0.0007), D12 (0.0588), D13 (0.4840), D14 (0.1344), D15 (0.2146), D16 (0.0702), D17
(0.0167), D18 (0.0134) and D19 (0.0067)]. Only three of the 10 alleles occurred at more than 10% frequency in these data. The frequencies
of the common alleles in controls were as follows: D13 (0.485), D14 (0.139), and D15 (0.207); the frequencies of the corresponding alleles in
cases were as follows: D13 (0.483), D14 (0.133), and D15 (0.218). We tested for association with this marker by testing each of the three
common alleles, in turn, against the rest, pooled. In the above table, only results for the allele showing the most evidence for association
are listed. Note that the variant with 13 D residues (D13) is the most common variant in both Japanese and Caucasian samples (D13
freq, 0.48 in Caucasians vs 0.67 in Japanese). However, the variant with 14 D residues (D14), for which association was reported in Japanese
samples, is fairly common in Caucasians (D14 freq, 0.13 in Caucasians vs 0.05 in Japanese).
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95% CI 1.22e2.78), and SNP RS7860786 (P¼ 0.012;
OR¼ 0.51, 95% CI 0.34e0.77). For SNPs RS7033979,
RS1924243 and RS7860786, ORs for genotypes homozy-
gous for the minor allele were similar to ORs for the hetero-
zygous genotypes, suggesting that variation at these sites
might be associated with OA in a dominant fashion. For
SNPs RS8067 and RS3739606, the association with OA
was limited to genotypes homozygous for the minor allele.
None of these associations remained statistically signiﬁcant
after adjusting for multiple testing. Furthermore, these nom-
inal genotype associations were not observed with allelic
tests or combinations of alleles (haplotype tests) across
the gene.Discussion
The purpose of the present study was to assess the as-
sociation of variants in the ASPN gene with OA in a US
Caucasian population. An association between OA and
functional polymorphisms in the ASPN gene was reported
in Japanese and Han Chinese populations5e7. Subsequent
replication studies in European Caucasian populations
were unable to demonstrate an association with the D14
allele, the risk allele in the Japanese and Chinese
studies8e10. However, knee OA studies in all three Euro-
pean populations did show a decreased allelic frequency
of the D13 allele (protective allele) and increased D14 fre-
quency in the case group, paralleling the trend in the Japa-
nese study. Recently, Valdes et al. performed an analysis of
combined data from all three European Caucasian studies
and provided some evidence of an association between
the D14 allele and an increased risk of OA17. Furthermore,
results from these combined data were suggestive ofa decreased risk of knee OA in carriers of the D13 allele.
This raises the possibility of an association between
ASPN and knee OA in Caucasian, as well as Japanese
and Chinese, populations. A similar trend was not observed
in the present study; carriers of the D13 allele variant did
show an association with a reduced risk of knee OA but
this trend was not statistically signiﬁcant (P¼ 0.06). In addi-
tion, variants in the D repeat polymorphism and SNPs in
linkage disequilibrium with this repeat (haplotypes) were
not found to be associated with knee OA in this study,
although it is possible that the study did not capture all
the genetic variation necessary to fully mark this allele.
The Japanese study that identiﬁed association with the
D repeat polymorphism and OA was conducted in patients
with knee OA (n¼ 530) and hip OA (n¼ 593) compared
with 374 controls5. More recent studies in Caucasian popu-
lations8,17 have investigated a similar number of patient
samples. Power estimates performed by Mustafa et al.8
suggested that with approximately 300 patients with knee
OA, there was a greater than 80% power to detect genetic
association when the OR was 1.5; an OR of 1.5 was smaller
than the smallest OR observed in the Japanese study. The
equivalent number of independent cases analyzed in the
present study, on average, was 570 patients, allowing for
familial correlation in siblings, and 511 matched controls.
This study was, therefore, comparable in size with previous
studies investigating the impact of the D repeat variant in
Caucasian populations, and was powered to detect modest
genetic effects, if they existed.
In summary, evidence to support the hypothesis that
ASPN is involved in OA susceptibility is not substantiated
by the data from the Caucasian cohort analyzed in this
study. However, as previously shown, it would be useful
to explore the possibility of performing a combined analysis
of several Caucasian samples with similar inclusion criteria
1177Osteoarthritis and Cartilage Vol. 16, No. 10and disease classiﬁcation to further elucidate the role of
ASPN as a susceptibility gene in OA. Interestingly, an inﬂu-
ence of ASPN polymorphism on the outcome of rheumatoid
arthritis has been reported18, although it had no association
with susceptibility to the disease. This raises the possibility
that the inﬂuence of ASPN extends beyond OA to a broader
spectrum of bone and joint diseases.Conﬂict of interest
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